- Join Us
- About the Event
- About CRI
- Why Immunotherapy
Join us on June 10, 2017 in West Point, NY for the 2nd annual Answer to Cancer.
Stephen, diagnosed with metastatic colorectal cancer at 28, enrolled in a clinical trial for a checkpoint inhibitor, a type of immunotherapy.
Read Stephen's Story
Deborah, who was treated with the immunotherapy Yervoy" in combination with radiation for stage III melanoma, participated in the 2016 Answer to Cancer cycling event to raise funds for CRI.
Read Deborah's Story
In 2012, life-long Tennessean Philip was shocked to learn that he had kidney cancer. Not satisfied with the chemotherapy options presented to him, Philip enrolled a clinical trial for the immunotherapy nivolumab (Opdivo").
Read Philip's Story
|Top 5 Teams||Donations Raised|
|1 | Team Basin||$2,100|
|2 | Team Cancer Research Institute||$1,100|
|3 | Skadden||$1,000|
|4 | Team Ellen||$1,000|
|5 | Team CD&R||$925|